Patents by Inventor Fazal Khan

Fazal Khan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10226501
    Abstract: A method for treating a cancer in a mammal using an extract of a Phoenix dactylifera (i.e. date) fruit flesh is described, along with an extraction method. The extract may be formed into a dried powder and reconstituted into a variety of media for oral administration, intravenous administration, or other routes. The extract may also be administered to prevent the occurrence of cancer or to treat other ailments.
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: March 12, 2019
    Assignee: King Abdulaziz University
    Inventors: Taha Abdullah Kumosani, Elie Kamil Barbour, Fazal Khan, Kalamegam Gauthaman, Adel Abuzenadah
  • Publication number: 20180360902
    Abstract: A method for treating a cancer in a mammal using an extract of a Phoenix dactylifera (i.e. date) fruit flesh is described, along with an extraction method. The extract may be formed into a dried powder and reconstituted into a variety of media for oral administration, intravenous administration, or other routes. The extract may also be administered to prevent the occurrence of cancer or to treat other ailments.
    Type: Application
    Filed: June 14, 2017
    Publication date: December 20, 2018
    Applicant: King Abdulaziz University
    Inventors: Taha Abdullah KUMOSANI, Elie Kamil Barbour, Fazal Khan, Kalamegam Gauthaman, Adel Abuzenadah
  • Patent number: 6869927
    Abstract: The invention is directed to liquid and lyophilized forms of Keratinocyte Growth Factor-2 (KGF-2) and derivatives thereof. This invention further relates to the formulation of KGF-2 for therapeutic use, for example, to promote or accelerate wound healing.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: March 22, 2005
    Assignee: Human Genome Sciences, Inc.
    Inventors: Reiner L. Gentz, Arvind Chopra, Parveen Kaushal, Thomas Spitznagel, Edward Unsworth, Fazal Khan
  • Publication number: 20040063639
    Abstract: The invention is directed to liquid and lyophilized forms of Keratinocyte Growth Factor-2 (KGF-2) and derivatives thereof. This invention further relates to the formulation of KGF-2 for therapeutic use, for example, to promote or accelerate wound healing.
    Type: Application
    Filed: October 30, 2003
    Publication date: April 1, 2004
    Applicant: Human Genome Sciences, Inc.
    Inventors: Reiner L. Gentz, Arvind Chopra, Parveen Kaushal, Thomas Spitznagel, Edward Unsworth, Fazal Khan
  • Patent number: 6653284
    Abstract: The invention is directed to liquid and lyophilized forms of Keratinocyte Growth Factor-2 (KGF-2) and derivatives thereof. This invention further relates to the formulation of KGF-2 for therapeutic use, for example, to promote or accelerate wound healing.
    Type: Grant
    Filed: May 14, 2001
    Date of Patent: November 25, 2003
    Assignee: Human Genome Sciences, Inc.
    Inventors: Reiner L. Gentz, Arvind Chopra, Parveen Kaushal, Thomas Spitznagel, Edward Unsworth, Fazal Khan
  • Publication number: 20020016295
    Abstract: The invention is directed to liquid and lyophilized forms of Keratinocyte Growth Factor-2 (KGF-2) and derivatives thereof. This invention further relates to the formulation of KGF-2 for therapeutic use, for example, to promote or accelerate wound healing.
    Type: Application
    Filed: May 14, 2001
    Publication date: February 7, 2002
    Applicant: Human Genome Sciences, Inc.
    Inventors: Reiner L. Gentz, Arvind Chopra, Parveen Kaushal, Thomas Spitznagel, Edward Unsworth, Fazal Khan